Esther Larrea
- Hepatology top 0.5%
- Hepatitis C virus research 23
- Immunology top 5%
- interferon and immune responses 10
- Immunotherapy and Immune Responses 8
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 8
- Biological Psychiatry top 5%
- Epidemiology top 5%
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 6
-
- Research on Leishmaniasis Studies 13
-
- Systemic Lupus Erythematosus Research 8
- Co-authors
- Jesús PrìetoJosé Ignacio Riezu‐BojPablo SarobeJuan José LasarteIgnacio MeleroM.P. CiveiraCarlos AlfaroBruno Sangro
- Cited by
- HepatologyImmunologyOncology
- Partner nations
- SpainFranceUnited States
In The Last Decade
Esther Larrea
64 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hepatology 1.1k
- Immunology 891
- Oncology 816
- Biological Psychiatry 72
- Epidemiology 804
Countries citing papers authored by Esther Larrea
This map shows the geographic impact of Esther Larrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Larrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Larrea more than expected).
Fields of papers citing papers by Esther Larrea
This network shows the impact of papers produced by Esther Larrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Larrea. The network helps show where Esther Larrea may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esther Larrea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 8 | |
| 3 | 2018 | 17 | |
| 4 | 2017 | 5 | |
| 5 | 2017 | 21 | |
| 6 | 2016 | 6 | |
| 7 | 2015 | 15 | |
| 8 | 2015 | 11 | |
| 9 | 2015 | 16 | |
| 10 | 2013 | 20 | |
| 11 | A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis Cbreakdown → | 2013 | 764 |
| 12 | 2012 | 18 | |
| 13 | 2011 | 37 | |
| 14 | 2007 | 58 | |
| 15 | 2005 | 72 | |
| 16 | 2004 | 35 | |
| 17 | 2004 | 10 | |
| 18 | 1999 | 93 | |
| 19 | 1996 | 76 | |
| 20 | 1993 | 20 |
About Esther Larrea
Esther Larrea is a scholar working on Hepatology, Immunology and Oncology, having authored 66 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), Research on Leishmaniasis Studies (13 papers), interferon and immune responses (10 papers), Immunotherapy and Immune Responses (8 papers), Systemic Lupus Erythematosus Research (8 papers), Cytokine Signaling Pathways and Interactions (8 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Hepatology (1.1k citations), Immunology (891 citations) and Oncology (816 citations). Esther Larrea has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Jesús Prìeto, José Ignacio Riezu‐Boj, Pablo Sarobe, Juan José Lasarte, Ignacio Melero, M.P. Civeira, Carlos Alfaro, Bruno Sangro, Mercedes Iñarrairaegui and José Luis Perez‐Gracia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.